EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.
about
Elucidating immunometabolic targets in glioblastoma.EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.Genomic alterations of ERBB receptors in cancer: clinical implications.Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.Malignant mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma harboring an EGFR mutation: a case reportA Critical Overview of Targeted Therapies for Glioblastoma
P2860
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.
@en
type
label
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.
@en
altLabel
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
@en
prefLabel
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.
@en
P2860
P1433
P1476
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
@en
P2093
Cecile L Maire
Katrin Lamszus
P2860
P2888
P304
P356
10.1007/S40263-017-0456-6
P407
P5008
P577
2017-09-01T00:00:00Z
P6179
1091106769